Navigation Links
PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022
Date:1/15/2014

hat Induces Disease Remission 576.2.6 Improved Quality of Life for Both Patients and their Carers 586.3 Unmet Needs Gap Analysis 586.4 Opportunities 606.4.1 Increase Treatment Armamentarium for Severe Recalcitrant Patients 606.4.2 Predictive Tests for Patient Stratification 606.4.3 More Therapeutic Options that Address Patients' Pruritus 617 Pipeline Assessment 627.1 Overview 627.2 Promising Drugs in Clinical Development 647.2.1 Phase II Pipeline Products 668 Market Outlook 678.1 Global Drivers and Barriers 678.1.1 Driver: Anticipated launch of the first biologic for the treatment of moderate to severe disease 678.1.2 Driver: The underserved severe refractory patient segment presents an untapped market opportunity 688.1.3 Driver: A drug that is able to target two or more atopic diseases would gain a foothold in these markets 688.1.4 Driver: Atopic dermatitis presents an attractive patient population for drug developers 688.1.5 Driver: Restoring skin barrier function remains a key goal of disease management, meaning a continued need for moisturizers and topical agents 698.1.6 Barrier: First to second line of therapy is dominated by cheap, genericized topical drugs which create significant obstacles for novel drugs hoping to penetrate the market 708.1.7 Barrier: The largest atopic dermatitis patient segment - mild disease - can be well-controlled on most forms of topical therapy 708.1.8 Barrier: Pediatric sufferers are the largest patient group and pose a high bar in terms of safety for new products 708.1.9 Barrier: The complexity of the multiple etiologies that lead to atopic dermatitis means that treatment outcomes with existing drugs are not universal across all patient groups 718.1.10 Barrier: A significant proportion of patients experience disease remission in their early adolescent years and this may occur without drug therapy 728.2 India 738.2.1 Forecast 738.2.2 Key Events 758.2.3 Drivers and Barriers 769 Appendix 789.1 Bibliography 78
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022
2. PharmaPoint: Alzheimers Disease - China Drug Forecast and Market Analysis to 2022
3. PharmaPoint: Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022
4. PharmaPoint: Dry Eye Syndrome - China Drug Forecast and Market Analysis to 2022
5. PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022
6. PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022
7. PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022
8. PharmaPoint: Osteoporosis - US Drug Forecast and Market Analysis to 2022
9. PharmaPoint: Osteoporosis - India Drug Forecast and Market Analysis to 2022
10. Signum Dermalogix Receives $1.6M Phase II SBIR Grant for the Development of Novel Atopic Dermatitis Therapeutics
11. Sanofi and Regeneron Report Positive Proof-of-Concept Data for Dupilumab, an IL-4R alpha Antibody, in Atopic Dermatitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Scott Steiger lives in St. Louis ... for the past 20 years, he,s traveled extensively and prior to ... to six of the seven continents. Travel is a big part ... Photo - http://photos.prnewswire.com/prnh/20141126/161077 So when he ... idea of what,s required. His latest creation is the ...
(Date:11/26/2014)... PORTLAND, Oregon , November 26, 2014 ... or fascia of the organ protrudes through the wall of ... weak muscle area at birth are some of the causes ... inguinal, umbilical, hiatal, femoral, and incisional. An inguinal hernia is ... area. An umbilical hernia is found in the area of ...
(Date:11/26/2014)...  CARsgen, a leader in the development of Chimeric ... variety of cancers, today announced the completion of a ... China -based healthcare private equity fund.   ... development of new therapeutics for liver, lung, stomach and ... Shanghai Renji Hospital, the company plans to initiate clinical ...
Breaking Medicine Technology:Steiger Has Created the First Pill Case Specifically Designed For Travel 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 3Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 4CARsgen Completes Series A Financing 2
... VILLA GUARDIA (COMO), Italy--(BUSINESS WIRE)--Apr 23, 2007 ... reported that,its lead product, Defibrotide, will be ... World Congress of Nephrology 2007 being held ... 2007., On Monday, April 23, 2007, Cinara ...
... The weight loss medication Xenical,(orlistat 120mg) significantly reduces ... pressure, glycaemic,control and lipid profile in overweight and ... to a study analysis,presented at the European Congress ... the wealth of data already established,for Xenical that ...
Cached Medicine Technology:Gentium's Defibrotide Highlighted in Poster Presentation at World,Congress of Nephrology 2Gentium's Defibrotide Highlighted in Poster Presentation at World,Congress of Nephrology 3New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 2New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 3New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 4New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 5New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 6
(Date:11/26/2014)... Dr. Rod J. Rohrich, ... in the Department of Plastic Surgery at UT ... fat grafting, and modern lift-and-fill facelifts before colleagues ... held by the American Society of Plastic Surgeons ... facial structure were explored in detail during Dr. ...
(Date:11/26/2014)... Amy Norton HealthDay Reporter ... people have long believed their dogs understand what they,re saying, ... emotion of words in a human-like way. Past research ... speech -- including the actual content and the emotional tone, ... give a deeper insight into the canine brain, according to ...
(Date:11/26/2014)... (HealthDay News) -- More than half of Americans with ... memory skills, a new study suggests. As ... 1.8 million Americans over the age of 70 with ... [mental] abilities," study author Dr. Vikas Kotagal, of the ... in a journal news release. The finding is ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 The ... Cardiology have launched a partnership designed to improve ... for congestive heart failure (CHF) patients in the ... staff and Lourdes Cardiology team will help CHF ... supervised protocols. This partnership pairs the Cardiac Recovery ...
(Date:11/26/2014)... 26, 2014 German scientists say carbon-based ... can cause mesothelioma that looks and acts similar to ... article on the research. Click here to read ... for Toxicology and Experimental Medicine in Hannover injected 500 ... of the rats eventually developed mesothelioma , how ...
Breaking Medicine News(10 mins):Health News:Dr. Rod J. Rohrich Discusses Facelifts at ASPS Annual Assembly 2Health News:Dr. Rod J. Rohrich Discusses Facelifts at ASPS Annual Assembly 3Health News:Your Dog Really Is Listening to You 2Health News:Your Dog Really Is Listening to You 3Health News:Too Few Americans Undergo Dementia Screening 2Health News:Advanced Heart Failure Recovery Program comes to Deptford Center for Rehabilitation and Healthcare 2Health News:Advanced Heart Failure Recovery Program comes to Deptford Center for Rehabilitation and Healthcare 3Health News:Multi-walled Nanotubes Linked to Mesothelioma in New Study, According to Surviving Mesothelioma 2
... has been experiencing phenomenal population growth since the beginning ... stagnation attributable to the slave trade and colonization. The ... 1900 to 770 million in 2005. The latest United ... of 1.5 to 2 billion inhabitants being reached between ...
... freeze-dried tendon grafts loaded with gene therapy may ... goal that has eluded surgeons to date. According ... Molecular Therapy, a new graft technique may provide ... tissue can reorganize as it heals. Such tissue-engineering ...
... Teti, Jr. will continue as Chairman of the Board, ... announced today that the Board of Directors has named ... Mr. Daly will continue as,Chief Financial Officer (CFO) of ... Officer Nicholas L. Teti, Jr. will continue to serve ...
... BRAINTREE, Mass., Jan. 8 Haemonetics,Corporation (NYSE: HAE ) will announce its ... am conference call., Conference Call Dial-In Information ... (973) 935-8754 (International) ID: 30405896 ... access the replay, please dial:, (800) ...
... System Purchased for Installation in Bangalore, SUNNYVALE, ... ), a global leader in the field of ... purchased a,CyberKnife(R) Robotic Radiosurgery System for its new ... 2008, this will be the first,CyberKnife System in ...
... Day, Senior Vice,President and Group Publisher at Dowden Health ... publisher of Current Psychiatry., "Ken is a seasoned ... years of experience and recognition across the media, account, ... is a subsidiary of,Lebhar- Friedman, Inc., Ken spent ...
Cached Medicine News:Health News:Sub-Saharan Africa: the population emergency 2Health News:Sub-Saharan Africa: the population emergency 3Health News:Freeze-dried tendon implants prove effective in early studies 2Health News:Freeze-dried tendon implants prove effective in early studies 3Health News:Freeze-dried tendon implants prove effective in early studies 4Health News:Freeze-dried tendon implants prove effective in early studies 5Health News:Isolagen Inc. Promotes Declan Daly to Chief Executive Officer (CEO) 2Health News:Isolagen Inc. Promotes Declan Daly to Chief Executive Officer (CEO) 3Health News:CyberKnife Radiosurgery Expands to India 2Health News:CyberKnife Radiosurgery Expands to India 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: